Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma

Cutaneous angiosarcoma is a rare and highly aggressive skin malignancy. The aim of this study is to explore the alteration of serum-derived extracellular vesicle (EV) in angiosarcoma patients and to evaluate its clinical utility as a novel circulating biomarker. In a microarray analysis to examine t...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazunori Yokoi, Jing Wang, Yusuke Yoshioka, Yasuhiro Fujisawa, Manabu Fujimoto, Takahiro Ochiya, Atsushi Tanemura
Format: Article
Language:English
Published: Medical Journals Sweden 2025-02-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access:https://medicaljournalssweden.se/actadv/article/view/40902
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850231274960060416
author Kazunori Yokoi
Jing Wang
Yusuke Yoshioka
Yasuhiro Fujisawa
Manabu Fujimoto
Takahiro Ochiya
Atsushi Tanemura
author_facet Kazunori Yokoi
Jing Wang
Yusuke Yoshioka
Yasuhiro Fujisawa
Manabu Fujimoto
Takahiro Ochiya
Atsushi Tanemura
author_sort Kazunori Yokoi
collection DOAJ
description Cutaneous angiosarcoma is a rare and highly aggressive skin malignancy. The aim of this study is to explore the alteration of serum-derived extracellular vesicle (EV) in angiosarcoma patients and to evaluate its clinical utility as a novel circulating biomarker. In a microarray analysis to examine the differential expression of specific EV-associated microRNAs in sera between cutaneous angiosarcoma patients and healthy controls, 73 microRNAs with significant upregulation and 100 microRNAs with significant downregulation, respectively, were identified in patients with angio-sarcoma. Among them, quantitative PCR confirmed that miR-184, miR-3925-5p, miR-3926, and miR-5703 were upregulated in sera of cutaneous angiosarcoma patients compared with those of healthy controls and melanoma patients. Additionally, these 4 microRNAs were expressed more highly in angiosarcoma cell lines compared with normal human endothelial cell lines and were prone to elevate along with disease progression. Furthermore, a gene analysis predicted that the target gene set of microRNAs might affect the regulation of TP53 via the epigenetic regulation of MECP2. Taken together, these 4 extracellular vesicle-associated microRNAs in circulation serve as a promising liquid biomarker to identify angiosarcoma patients and trace disease progression.
format Article
id doaj-art-c83d3851ad804a0a86fedb0efd462de7
institution OA Journals
issn 0001-5555
1651-2057
language English
publishDate 2025-02-01
publisher Medical Journals Sweden
record_format Article
series Acta Dermato-Venereologica
spelling doaj-art-c83d3851ad804a0a86fedb0efd462de72025-08-20T02:03:35ZengMedical Journals SwedenActa Dermato-Venereologica0001-55551651-20572025-02-0110510.2340/actadv.v105.40902Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in AngiosarcomaKazunori Yokoi0https://orcid.org/0000-0003-0582-7325Jing Wang1Yusuke Yoshioka2Yasuhiro Fujisawa3Manabu Fujimoto4Takahiro Ochiya5Atsushi Tanemura6https://orcid.org/0000-0002-5239-8474Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanDepartment of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanDepartment of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, JapanDepartment of Dermatology, Tsukuba University, Tsukuba, Ibaraki, JapanDepartment of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanDepartment of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, JapanDepartment of Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanCutaneous angiosarcoma is a rare and highly aggressive skin malignancy. The aim of this study is to explore the alteration of serum-derived extracellular vesicle (EV) in angiosarcoma patients and to evaluate its clinical utility as a novel circulating biomarker. In a microarray analysis to examine the differential expression of specific EV-associated microRNAs in sera between cutaneous angiosarcoma patients and healthy controls, 73 microRNAs with significant upregulation and 100 microRNAs with significant downregulation, respectively, were identified in patients with angio-sarcoma. Among them, quantitative PCR confirmed that miR-184, miR-3925-5p, miR-3926, and miR-5703 were upregulated in sera of cutaneous angiosarcoma patients compared with those of healthy controls and melanoma patients. Additionally, these 4 microRNAs were expressed more highly in angiosarcoma cell lines compared with normal human endothelial cell lines and were prone to elevate along with disease progression. Furthermore, a gene analysis predicted that the target gene set of microRNAs might affect the regulation of TP53 via the epigenetic regulation of MECP2. Taken together, these 4 extracellular vesicle-associated microRNAs in circulation serve as a promising liquid biomarker to identify angiosarcoma patients and trace disease progression. https://medicaljournalssweden.se/actadv/article/view/40902AngiosarcomaSerumExtracellular vesicleMicroRNABiomarker
spellingShingle Kazunori Yokoi
Jing Wang
Yusuke Yoshioka
Yasuhiro Fujisawa
Manabu Fujimoto
Takahiro Ochiya
Atsushi Tanemura
Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma
Acta Dermato-Venereologica
Angiosarcoma
Serum
Extracellular vesicle
MicroRNA
Biomarker
title Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma
title_full Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma
title_fullStr Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma
title_full_unstemmed Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma
title_short Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma
title_sort novel detection and clinical utility of serum derived extracellular vesicle in angiosarcoma
topic Angiosarcoma
Serum
Extracellular vesicle
MicroRNA
Biomarker
url https://medicaljournalssweden.se/actadv/article/view/40902
work_keys_str_mv AT kazunoriyokoi noveldetectionandclinicalutilityofserumderivedextracellularvesicleinangiosarcoma
AT jingwang noveldetectionandclinicalutilityofserumderivedextracellularvesicleinangiosarcoma
AT yusukeyoshioka noveldetectionandclinicalutilityofserumderivedextracellularvesicleinangiosarcoma
AT yasuhirofujisawa noveldetectionandclinicalutilityofserumderivedextracellularvesicleinangiosarcoma
AT manabufujimoto noveldetectionandclinicalutilityofserumderivedextracellularvesicleinangiosarcoma
AT takahiroochiya noveldetectionandclinicalutilityofserumderivedextracellularvesicleinangiosarcoma
AT atsushitanemura noveldetectionandclinicalutilityofserumderivedextracellularvesicleinangiosarcoma